Current shareholders must have their shares into OTC Corporate Transfer Service Company by May 4, 2007, unless extended by the Company, in order to qualify for the exchange of common shares to Series B Convertible Preferred Shares. In order to qualify for the exchange, shareholders must submit a minimum of 100,000 shares of common stock.
-------------------- In the end, trust only yourself when trading stocks. Posts: 2048 | From: Texas | Registered: Feb 2006
| IP: Logged |
posted
Down to 3 MMs and a lot of shares just sold , dont look like they want to wait to transfer sh.. Not sure what I will do but only have 500000 sh and not sure how long would have to hold for transfer ,
Posts: 1986 | From: Florida | Registered: Mar 2006
| IP: Logged |
quote:Originally posted by megahead34: Say i have 1 million shares (common). If i convert, i will have 1000 preferred valued at $1.00?
They don't really explain how to convert. What process do we take?
most likely these will be restricted for one or two years and convertable at the stock price at that time in shares, so if the price "then" is .0001 they will convert into 10,000 shares of common "if" the price is less than .0001?????
Posts: 2503 | From: connecticut | Registered: Mar 2005
| IP: Logged |
posted
Is anyone still in this? Any News? Updates? PR? WORD ON WHEN I'M GOING TO MAKE A RETURN ON MY $$$$$$$?
Posts: 109 | From: Charlotte, NC | Registered: Feb 2007
| IP: Logged |
posted
LBTN just a matter of time for the approval of the technology.Lifeline Biotechnologies, Inc. to Release Initial Report on First Warning's(TM) New Algorithm May 1, 2007 8:31:00 AM Copyright Business Wire 2007 RENO, Nev.--(BUSINESS WIRE)--
Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced that diagnostic success appears on the horizon for Lifeline's First Warning System(TM) which is designed to assist in the early detection of breast cancer. The company is expecting to soon release a promising initial report on its new algorithm developed by its study group.
Louis Keith, MD, PhD, Lifeline's Medical Director and Vice President, stated that on their recent visit to SE Asia, he and Jim Holmes, Lifeline's CEO, met with two eminent scientists of a prestigious technical university, engineers in the field of pattern recognition. These engineers, associated with Lifeline during the last three years, are assisting the Company in the development of new neural networks and have been working with the process to eliminate noise for the patient thermal data recorded by the First Warning System(TM). Thus far, the preliminary results have produced much better results in terms of reducing false positive and false negative interpretations.
Jim Holmes stated, "The Company's next step is to examine a larger group of women to verify what we have discovered."
Posts: 660 | From: california | Registered: Nov 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Eek!]](eek.gif)
